证券代码:002940 证券简称:昂利康 公告编号:2025-080

Group 1 - The core point of the announcement is that the actual controller of Zhejiang Anglikang Pharmaceutical Co., Ltd., Mr. Lü Huaihao, has completed a partial repurchase and release of pledged shares [1] - As of November 5, 2025, the status of pledged shares held by the shareholder and their concerted parties is disclosed, indicating the number of pledged shares and those under lock-up or freezing [1] - The company assures that Mr. Lü Huaihao has a good credit status and sufficient repayment ability, and there are no risks of forced liquidation or transfer of ownership, which will not affect the company's operations or governance [1][2] Group 2 - The company will continue to monitor the changes and risks related to share pledges and will fulfill its information disclosure obligations in a timely manner [2] - The announcement includes a reference to the documentation proving the release of the pledged shares [3] - The announcement is officially made by the board of directors of Zhejiang Anglikang Pharmaceutical Co., Ltd. on November 7, 2025 [5]